SEC Form 4 · accession 0001618835-19-000020
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Saundra L Pelletier
Officer — Chief Executive Officer · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 25, 2019 | A | 150,000 | $0.00 | A | 491,813 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2019.